均瑶健康：预计2025年净亏损1.44亿至2.16亿元，前置性销售费用及市场费用较大幅度增长

Core Viewpoint - Junyao Health expects a net loss of 144 million to 216 million yuan for the year 2025, indicating significant financial challenges ahead [1] Group 1: Performance Outlook - The company anticipates a net loss of 144 million to 216 million yuan for 2025 [1] - The decline in market share for dairy beverages and weak downstream customer demand have contributed to reduced revenue from traditional ambient yogurt business compared to the same period last year [2] Group 2: Cost and Investment Factors - The company has increased upfront sales and marketing expenses significantly compared to the previous year due to efforts to optimize revenue structure and expand e-commerce, new retail, and chain KA channels [2] - Increased R&D investment has led to a rise in research expenses during the reporting period [2] Group 3: Asset Impairment and Provisions - The company plans to recognize asset impairment provisions for at-risk inventory, expected to impact profits by 30 million to 50 million yuan, with final amounts to be determined by external assessment [2] - Credit risk on certain receivables has increased, prompting the company to consider credit impairment provisions, estimated to affect profits by 50 million to 90 million yuan, with final amounts subject to external evaluation [2] - The company intends to recognize goodwill impairment provisions for certain subsidiaries, expected to impact profits by 15 million to 45 million yuan, with final amounts to be assessed by external evaluators [2]